If we are able to detect C-circle DNA with adequate sensitivity/specificity, we would expand this to a larger study and if validated, could consider incorporation to a future trial for patients who are entered on a retrospective (or prospective study) for patients whose tumors are ALT positive.
Get the Latest
news, articles, and resources sent to your inbox.